Showing results (1-10 of 460) with videos related to
Sort By:
Pageof 46
Oncology (Williston Park, N.Y.)|July 11, 2002
Docetaxel and radiation as combined-modality therapyEdward S Kim, Fadlo R KhuriCancer Prevention Research (Philadelphia, Pa.)|July 8, 2011
The dawn of a revolution in personalized lung cancer preventionFadlo R KhuriOncology (Williston Park, N.Y.)|July 11, 2002
Docetaxel for locally advanced or metastatic non-small-cell lung cancer. Current data and future directions as front-line therapyFadlo R KhuriFASEB Bioadvances|September 6, 2021
In Lebanon "It Never Rains But It Pours"-How the American University of Beirut faced dangers and seized opportunities: Transforming medical education through multiple crisesFadlo R KhuriClinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 5, 2008
Insulin-like growth factor-I receptor signaling pathway induces resistance to the apoptotic activities of SCH66336 (lonafarnib) through Akt/mammalian target of rapamycin-mediated increases in survivin expressionSeung Hyun Oh, Quanri Jin, Edward S Kim, et al.Current Opinion in Pulmonary Medicine|June 29, 2004
Chemoprevention of lung cancerVictor Cohen, Fadlo R KhuriTreatments in Respiratory Medicine|May 16, 2006
Taxanes in the treatment of non-small cell lung cancerMichael Fanucchi, Fadlo R KhuriClinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 26, 2004
Molecularly targeted approaches to the chemoprevention of lung cancerFadlo R Khuri, Victor CohenCancer Metastasis Reviews|January 29, 2003
Chemoprevention of lung cancer: current status and future prospectsVictor Cohen, Fadlo R KhuriPageof 46